# Pheon Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pheon-therapeutics

- Industry: Biotechnology
- Headquarters: London, UK
- Website: www.pheontx.com
- Total disclosed funding: $189M
- Latest round: Series B (May 21, 2024)
- Investors on record: 8

## About

Founded in 2022 by its vice president, research and development, Paul Jackson, and advisor, David Thurston, and based in London, UK, Pheon Therapeutics Ltd., operates as a developer of antibody-drug conjugate that could help treat cancer patients. In September 2022, Pheon Therapeutics Ltd. raised USD 68 million in series A funding led by Brandon Capital Partners, with participation from other investors, Atlas Venture, Forbion, and Research Corporation Technologies. As of 2022, the company is led by its CEO, Bertrand Damour.

The company offers healthcare solutions by developing antibody-drug conjugates (ADCs) that are used to treat various hard-to-treat cancers. The company is currently working on two solid tumor projects that include PHN-010, and PHN-020.

The company will use the September 2022 funding to support its advanced research in novel cancer antigens.

## Funding rounds

- Series B, May 21, 2024, $120M — Atlas Venture, Lightspeed Venture Partners, Research Corporation Technologies, Brandon Capital Partners, Forbion, BVF Partners, Perceptive Advisors, TCG Crossover Management
- Series A, Mar 14, 2022, $69M — Atlas Venture, Research Corporation Technologies, Brandon Capital Partners, Forbion

## Investors

- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series A, Series B
- Research Corporation Technologies (https://capitalatlas.ai/funds/research-corporation-technologies) — Series A, Series B
- Brandon Capital Partners (https://capitalatlas.ai/funds/brandon-capital-partners) — Series A, Series B
- Forbion (https://capitalatlas.ai/funds/forbion) — Series A, Series B
- Lightspeed Venture Partners (https://capitalatlas.ai/funds/lightspeed-venture-partners) — Series B
- BVF Partners (https://capitalatlas.ai/funds/bvf-partners) — Series B
- Perceptive Advisors (https://capitalatlas.ai/funds/perceptive-advisors) — Series B
- TCG Crossover Management (https://capitalatlas.ai/funds/tcg-crossover-management) — Series B